Insider trades
Jeffrey Hessekiel, CLO of Cytokinetics CYTK, has filed 0 purchases and 13 sales on the open market. The latest trade was on 03/15.
Jeffrey Hessekiel
Chief Legal & Admin Officer
- Company
- Cytokinetics CYTK
- First filing
- 23/03/03
- Trades
- 51 trades
- Buys / sales
- 0 / 13
- 12-month net buying
- No record
- Last trade
- 03/15
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
ExelixisEXEL | Open-market sale | 25/05/15 | 25/05/16 | 25,000 sh | $46.18 | $1,154,500 | −3.5% |
ExelixisEXEL | Open-market sale | 24/11/29 | 24/12/02 | 60,000 sh | $36.67 | $2,200,200 | −11.0% |
ExelixisEXEL | Open-market sale10b5-1 plan | 24/11/01 | 24/11/05 | 50,000 sh | $34.13 | $1,706,500 | −8.6% |
ExelixisEXEL | Open-market sale10b5-1 plan | 24/10/28 | 24/10/30 | 25,000 sh | $28.39 | $709,750 | −4.1% |
ExelixisEXEL | Open-market sale10b5-1 plan | 24/09/23 | 24/09/25 | 25,000 sh | $26.38 | $659,500 | −4.0% |
ExelixisEXEL | Open-market sale10b5-1 plan | 24/08/26 | 24/08/28 | 20,000 sh | $25.79 | $515,800 | −3.1% |
ExelixisEXEL | Open-market sale10b5-1 plan | 24/08/07 | 24/08/09 | 80,000 sh | $25.97 | $2,077,600 | −11.3% |
ExelixisEXEL | Open-market sale10b5-1 plan | 23/12/13 | 23/12/14 | 25,000 sh | $23.01 | $575,250 | −4.5% |
EXEL | Open-market sale10b5-1 plan | 23/11/30–23/12/04 | 23/12/04 | 50,000 sh2 trades | $22.04avg. | $1,101,750 | −8.2% |
ExelixisEXEL | Open-market sale10b5-1 plan | 23/08/01 | 23/08/03 | 55,710 sh | $19.63 | $1,093,587.3 | −8.9% |
ExelixisEXEL | Open-market sale10b5-1 plan | 23/04/05 | 23/04/05 | 38,930 sh | $20.01 | $778,989.3 | −6.3% |
ExelixisEXEL | Open-market sale | 23/03/01 | 23/03/03 | 77,860 sh | $17.13 | $1,333,741.8 | −12.9% |
